Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Preliminary safety and efficacy of GX-17, a long-acting interleukin-7, in combination with pembrolizumab in patients with refractory or recurrent metastatic triple negative breast cancer (mTNBC): Dose escalation period of Phase Ib/II study (KEYNOTE-899).
- Authors
- Sohn, Joohyuk; Park, Kyong Hwa; Ahn, Hee Kyung; Lee, Keun Seok; Kim, Jee Hyun; Kim, Sung-Bae; Lee, Kyoung Eun; Kim, Jee Hung; Yang, Se Hwan; Le, Ngocdiep T.; Kim, Jiwon; Heo, MinKyu; Woo, Jung-Won; Sung, Young Chul; Im, Young Hyuck
- Issue Date
- 20200520
- Conference Name
- JOURNAL OF CLINICAL ONCOLOGY
- Place
- 미국
- Conference Name
- 2020 ASCO Annual Meeting
- ISSN
- 0732-183X
1527-7755
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Park, Kyong Hwa
- Anam Hospital (Department of Medical Oncology and Hematology, Anam Hospital)